Pacer Advisors Inc. Sells 14,012 Shares of Omega Healthcare Investors, Inc. $OHI

Pacer Advisors Inc. trimmed its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 28.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 35,342 shares of the real estate investment trust’s stock after selling 14,012 shares during the period. Pacer Advisors Inc.’s holdings in Omega Healthcare Investors were worth $1,567,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Mutual Advisors LLC increased its stake in Omega Healthcare Investors by 8.5% during the third quarter. Mutual Advisors LLC now owns 327,383 shares of the real estate investment trust’s stock valued at $13,321,000 after acquiring an additional 25,565 shares during the period. CPC Advisors LLC bought a new position in Omega Healthcare Investors during the fourth quarter valued at about $3,050,000. Bank of New York Mellon Corp increased its stake in Omega Healthcare Investors by 6.8% during the third quarter. Bank of New York Mellon Corp now owns 3,761,216 shares of the real estate investment trust’s stock valued at $158,799,000 after acquiring an additional 239,134 shares during the period. Bright Futures Wealth Management LLC. bought a new position in Omega Healthcare Investors during the third quarter valued at about $458,000. Finally, JPMorgan Chase & Co. increased its stake in Omega Healthcare Investors by 77.9% during the third quarter. JPMorgan Chase & Co. now owns 3,417,240 shares of the real estate investment trust’s stock valued at $144,278,000 after acquiring an additional 1,496,059 shares during the period. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Stock Down 0.3%

NYSE:OHI opened at $47.86 on Friday. The stock’s fifty day moving average price is $46.29 and its two-hundred day moving average price is $45.23. Omega Healthcare Investors, Inc. has a 52-week low of $35.70 and a 52-week high of $49.14. The company has a debt-to-equity ratio of 0.81, a quick ratio of 5.32 and a current ratio of 5.32. The company has a market cap of $14.25 billion, a price-to-earnings ratio of 23.12, a P/E/G ratio of 2.15 and a beta of 0.59.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Tuesday, April 28th. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.49 by ($0.02). Omega Healthcare Investors had a return on equity of 11.86% and a net margin of 51.14%.The firm had revenue of $322.96 million for the quarter, compared to analyst estimates of $264.07 million. During the same period in the prior year, the company posted $0.75 EPS. The firm’s quarterly revenue was up 16.7% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. On average, analysts anticipate that Omega Healthcare Investors, Inc. will post 3.06 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, May 4th will be paid a $0.67 dividend. The ex-dividend date of this dividend is Monday, May 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 5.6%. Omega Healthcare Investors’s dividend payout ratio is 129.47%.

Analyst Upgrades and Downgrades

OHI has been the topic of several analyst reports. Wells Fargo & Company upped their price objective on Omega Healthcare Investors from $45.00 to $47.00 and gave the company an “equal weight” rating in a research note on Thursday, March 26th. Citigroup increased their price target on Omega Healthcare Investors from $50.00 to $52.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Scotiabank increased their price target on Omega Healthcare Investors from $45.00 to $48.00 and gave the stock a “sector perform” rating in a research report on Monday, March 2nd. Weiss Ratings upgraded Omega Healthcare Investors from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Tuesday, April 21st. Finally, UBS Group increased their price target on Omega Healthcare Investors from $52.00 to $54.00 and gave the stock a “buy” rating in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Omega Healthcare Investors has an average rating of “Hold” and a consensus price target of $48.83.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.